首页> 中文期刊> 《山东医药》 >痰热清注射液治疗全身炎症反应综合征的系统评价

痰热清注射液治疗全身炎症反应综合征的系统评价

         

摘要

目的:系统评价痰热清注射液治疗全身炎症反应综合征的效果。方法检索Ovid/Pubmed、Embase、中国知网、万方数据知识服务平台、维普期刊资源整合服务平台、中国生物医学文献数据库,查找痰热清注射液治疗全身炎症反应综合征的随机对照试验(RCT),观察指标包括临床总有效率、WBC、血清C-反应蛋白(CRP)、TNF-α、血清降钙素原( PCT)、体温( T)。根据Jadad质量评分法对文献质量进行评价。结果最终纳入11篇文献,共811例患者,对照组396例、痰热清组415例。纳入文献质量总体不高,仅1篇为高质量文献。纳入文献存在发表偏倚。与对照组相比,痰热清组总有效率提高(OR=3.05,95%CI:1.46~6.39,P=0.003),WBC下降(WMD=1.39,95%CI:2.25~0.53,P=0.002),血清CRP(WMD=13.78,95%CI:19.96~7.60,P<0.0001)、PCT(SMD=2.17,95%CI:4.230.11,P=0.04)、TNF-α(SMD=-1.50,95%CI:2.14~0.85,P<0.00001)、IL-6(WMD=-24.04,95%CI:36.03~12.05,P<0.0001)降低,T降低(WMD=-0.66,95%CI:0.85~0.47,P<0.0001)。所有文献未报告痰热清注射液有不良反应。结论痰热清注射液治疗全身炎症反应综合征效果较好。%Objective To evaluate the efficacy of Tanreqing injection in treatment of systemic inflammatory response syndrome (SIRS) systematically.Methods We retrieved Ovid/Pubmed, Embase, CNKI, Wanfang data, VIP and Chi-nese biomedical literature database to search for the randomized controlled trial ( RCT) of Tanreqing injection in the treat-ment of SIRS , and then we observed the following indexes , including the clinical total effective rate , white blood cell count (WBC), serum C-reactive protein (CRP) and serum tumor necrosis factor-α(TNF-α), serum calcitonin (PCT) and tem-perature ( T) .According to the Jadad quality evaluation , we evaluated the literatures .Results Eleven trials were eligible finally, and contained 811 cases of patients including 396 patients treated with conventional treatment and 415 with Tan-reqing injection based on conventional treatment , only one literature was of high-quality.Meta analysis showed that the therapeutic effect of SIRS treated with Tanreqing injection was better than that treated by routine alone , and it reflected mainly in the following:the total clinical efficiency was increased (OR=3.05, 95%CI:1.46-6.39, P=0.003), the level of WBC (WMD=1.39,95%CI:2.25 to 0.53, P=0.002), the level of CRP (WMD=13.78, 95%CI:19.96 to 7.60, P<0.00 01), the level of PCT (SMD=2.17, 95%CI:4.23 to 0.11, P=0.04), the level of TNF-α(SMD=-1.50, 95%CI:2.14 to 0.85, P<0.00 001), and the level of IL-6 (WMD=-24.04,95%CI:36.03 to 12.05, P<0.00 01) were decreased, ant the level of T was decreased (WMD=-0.66, 95%CI:0.85 to 0.47, P<0.00 01).No serious adverse reactions were reported .Conclusion Tanreqing injection has good effect in treatment of SIRS .

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号